A Biomedical Cluster at our London Bridge site (including Guy’s Hospital) focused on advanced therapies, cellular medicine, cancer and biomedical sciences - building on the success of the Guy’s Cancer
Further capital investment in our
A MedTech Cluster at our Westminster Bridge
Centre and Guy’s Tower as centres for advanced therapies research.
community healthcare estate portfolio , thus enabling better integrated care for our communities, closer to where people live, by improving digital mobility of staff and diagnostic tools, encouraging people to manage their own health, and providing a network.
site (including St Thomas’s Hospital), building on the Trust’s existing strengths in emergency care, diagnostic imaging, paediatrics and
cardiovascular care and the University’s cardiovascular, imaging and healthcare engineering research.
LOOKING TO THE FUTURE PLANS
A c.£200m expansion of Evelina London Children’s Hospital, providing the full continuum of specialist care and delivering a comprehensive children’s hospital for London.
A partnership with Royal Brompton & Harefield NHS Foundation Trust that will transform specialist cardiovascular care for London and the UK.
The Trust will plan and deliver an estate that will be fit for purpose for decades to come, by designing “shell and core” buildings which can adapt quickly and easily to different uses, so that we can refit them every 10-15 years, depending on our needs. This is not a one-off exercise, but a sustained strategy of investment and growth that is financially sustainable over the long-term. Healthcare is rapidly changing. In the future the treatments and technologies available to patients may be radically different. We need buildings that are designed with a degree of flexibility and future-proofing. We aim to treble the amount of space across our estate from the current 381,000 sqm to 1.1M sqm by 2050. Space not required by the Trust and King’s Health Partners will be available to research institutions and life science industry partners, including startups and SMEs. Co-location of these uses is central to the development of our MedTech and Biomedical Clusters model.
Candidate Brochure 12
Made with FlippingBook Learn more on our blog